Synthesis, molecular docking and molecular dynamics simulation of 2- thioxothiazolidin-4-one derivatives against Gp41

(2020) Synthesis, molecular docking and molecular dynamics simulation of 2- thioxothiazolidin-4-one derivatives against Gp41. Curr HIV Res. pp. 47-60. ISSN 1570162X (ISSN)

Full text not available from this repository.

Abstract

Introduction: Gp41 and its conserved hydrophobic groove on the N-terminal heptad repeat region are attractive targets in the design of HIV-1 entry inhibitors. Linearly extended molecules have shown potent anti-HIV-1 activity for their effective interactions with the gp41 binding pocket. Rhodanine ring attached to substituted pyrrole or furan rings has been proved a preferred moiety to be inserted inside the molecular structure of the gp41 inhibitors. Objectives: Based on the previous findings we are going to describe some rhodanine derivatives in which a substituted imidazole ring is introduced in place of the pyrrole or furan rings. The compounds’ flexibility is increased by inserting methylene groups inside the main scaffold. Methods: Molecular docking and molecular dynamics simulations approaches were exploited to investigate the chemical interactions and the stability of the designed ligands-gp41 complex. All compounds were synthesized and their chemical structures were elucidated by 1HNMR, 13CNMR, FTIR and Mass spectroscopy. Biological activities of the compounds against HIV-1 and HIV-2 and their cellular toxicities against the T-lymphocyte (MT-4) cell line were determined. Results: All the designed compounds showed proper and stable chemical interactions with gp41 according to the in silico studies. The results of the biological tests proved none of the compounds active against HIV-1 replication in cell cultures. Conclusion: Since all the studied compounds were potently toxic for the host cell; it was therefore not possible to assess their anti-HIV activities. © 2021 Bentham Science Publishers.

Item Type: Article
Keywords: 2-thioxothiazolidin-4-one Anti-HIV Gp41 Molecular docking Molecular dynamics simulation Synthesis 2 thioxothiazolidin 4 one derivative 3 benzyl 2 thioxothiazolidin 4 one 3 phenethyl 2 thioxothiazolidin 4 one 4 ((2 (benzylthio) 5 ((4 oxo 3 phenethyl 2 thioxothiazolidin 5 ylidene)methyl) 1h imidazol 1 yl)methyl)benzoic acid 4 ((2 (methylthio) 5 ((4 oxo 3 phenethyl 2 thioxothiazolidin 5 ylidene)methyl) 1h imidazol 1 yl)methyl)benzoic acid 4 ((5 ((3 benzyl 4 oxo 2 thioxothiazolidin 5 yli dene)methyl) 2 (benzylthio) 1h imidazol 1 yl)methyl)benzoic acid 4 ((5 ((3 benzyl 4 oxo 2 thioxothiazolidin 5 yli dene)methyl) 2 (methylthio) 1h imidazol 1 yl)methyl)benzoic acid 4 ((5 (hydroxymethyl) 2 (alkyllthio) 1h imidazol 1 yl)methyl)benzoic acid derivative 4 ((5 (hydroxymethyl) 2 (benzylthio) 1h imidazol 1 yl)methyl)benzoic acid derivative 4 ((5 (hydroxymethyl) 2 (methylthio) 1h imidazol 1 yl)methyl)benzoic acid derivative 4 ((5 (hydroxymethyl) 2 mercapto 1h imidazol 1 yl)methyl)benzoic acid 4 ((5 formyl 2 (alkylthio) 1h imidazol 1 yl)methyl)benzoic acid derivative 4 ((5 formyl 2 (benzylthio) 1h imidazol 1 yl)methyl)benzoic acid derivative 4 ((5 formyl 2 (methylthio) 1h imidazol 1 yl)methyl)benzoic acid derivative 4 5 ((3 alkyl 4 oxo 2 thioxothiazolidin 5 yli dene)methyl) 2 (alkylthio) 1h imidazol 1 ylmethylbenzoic acid derivative glycoprotein gp 41 plerixafor rhodanine tenofovir unclassified drug anti human immunodeficiency virus agent antiviral activity Article carbon nuclear magnetic resonance cell mediated cytotoxicity computer model controlled study drug stability drug synthesis electrospray mass spectrometry Fourier transform infrared spectroscopy human human cell Human immunodeficiency virus 1 (strain NL4.3) Human immunodeficiency virus 2 Human immunodeficiency virus 2 (strain ROD) mass spectrometry molecular dynamics MT-4 cell line MTS assay protein localization proton nuclear magnetic resonance static electricity thin layer chromatography chemical structure chemistry drug effect Human immunodeficiency virus infection structure activity relation Anti-HIV Agents HIV Envelope Protein gp41 HIV Infections Humans Molecular Docking Simulation Molecular Structure Structure-Activity Relationship
Subjects: QV Pharmacology
Divisions: Faculty of Pharmacy and Pharmaceutical Sciences > گروه شیمی دارویی
Page Range: pp. 47-60
Journal or Publication Title: Curr HIV Res
Journal Index: Scopus
Volume: 19
Number: 1
Identification Number: https://doi.org/10.2174/1570162X18666200903172127
ISSN: 1570162X (ISSN)
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/18177

Actions (login required)

View Item View Item